250 related articles for article (PubMed ID: 18174260)
21. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD
Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933
[TBL] [Abstract][Full Text] [Related]
22. TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.
Baardsnes J; Hinck CS; Hinck AP; O'Connor-McCourt MD
Biochemistry; 2009 Mar; 48(10):2146-55. PubMed ID: 19161338
[TBL] [Abstract][Full Text] [Related]
23. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
24. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP
Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838
[TBL] [Abstract][Full Text] [Related]
25. Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.
Lynch MA; Petrel TA; Song H; Knobloch TJ; Casto BC; Ramljak D; Anderson LM; DeGroff V; Stoner GD; Brueggemeier RW; Weghorst CM
Gene Expr; 2001; 9(4-5):157-71. PubMed ID: 11444526
[TBL] [Abstract][Full Text] [Related]
26. X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression.
Neil JR; Tian M; Schiemann WP
J Biol Chem; 2009 Aug; 284(32):21209-17. PubMed ID: 19531477
[TBL] [Abstract][Full Text] [Related]
27. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
28. PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.
Tian M; Schiemann WP
FASEB J; 2010 Apr; 24(4):1105-16. PubMed ID: 19897661
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo.
Ge R; Rajeev V; Ray P; Lattime E; Rittling S; Medicherla S; Protter A; Murphy A; Chakravarty J; Dugar S; Schreiner G; Barnard N; Reiss M
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4315-30. PubMed ID: 16857807
[TBL] [Abstract][Full Text] [Related]
30. The TGF-beta type III receptor is localized to the medial edge epithelium during palatal fusion.
Cui XM; Shuler CF
Int J Dev Biol; 2000 Jun; 44(4):397-402. PubMed ID: 10949049
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
[TBL] [Abstract][Full Text] [Related]
32. Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.
Allington TM; Galliher-Beckley AJ; Schiemann WP
FASEB J; 2009 Dec; 23(12):4231-43. PubMed ID: 19690215
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical localization of TGF-beta type II receptor and TGF-beta3 during palatogenesis in vivo and in vitro.
Cui XM; Warburton D; Zhao J; Crowe DL; Shuler CF
Int J Dev Biol; 1998 Sep; 42(6):817-20. PubMed ID: 9727838
[TBL] [Abstract][Full Text] [Related]
34. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
36. TMED10 Protein Interferes with Transforming Growth Factor (TGF)-β Signaling by Disrupting TGF-β Receptor Complex Formation.
Nakano N; Tsuchiya Y; Kako K; Umezaki K; Sano K; Ikeno S; Otsuka E; Shigeta M; Nakagawa A; Sakata N; Itoh F; Nakano Y; Iemura SI; van Dinther M; Natsume T; Ten Dijke P; Itoh S
J Biol Chem; 2017 Mar; 292(10):4099-4112. PubMed ID: 28115518
[TBL] [Abstract][Full Text] [Related]
37. Lack of expression of transforming growth factor-beta type II receptor associated with malignant progression in human salivary gland cell clones.
Azuma M; Yuki T; Tamatani T; Motegi K; Yoshida H; Sato M
Int J Cancer; 1996 Jun; 66(6):802-5. PubMed ID: 8647653
[TBL] [Abstract][Full Text] [Related]
38. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
[TBL] [Abstract][Full Text] [Related]
39. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells.
Engel JD; Kundu SD; Yang T; Lang S; Goodwin S; Janulis L; Cho JS; Chang J; Kim SJ; Lee C
Urology; 1999 Jul; 54(1):164-70. PubMed ID: 10414746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]